Related Experiment Video

Updated: Jul 10, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Pediatric sepsis: the infection unto death

Patricia A Moloney-Harmon1

  • 1Children's Services, Sinai Hospital of Baltimore, 2401 W. Belvedere Avenue, Baltimore MD 21215, USA. pmoloney@lifebridgehealth.org

Critical Care Nursing Clinics of North America
|December 14, 2005
PubMed

Insights

Pediatric intensive care unit (ICU) patients often have infections that can lead to sepsis, a significant cause of mortality. This article discusses the unique challenges and implications of sepsis in infants and children.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Pediatric critical illness

Background:

  • Infectious diseases are common in pediatric intensive care unit (ICU) admissions.
  • Sepsis is a leading cause of mortality in critically ill infants and children.
  • Managing sepsis in pediatric patients is complex due to multifactorial causes and pathophysiology.

Purpose of the Study:

  • To focus on the specific implications of sepsis in infants and children.
  • To highlight the challenges in diagnosing and managing pediatric sepsis.
  • To provide insights into the pathophysiology of sepsis in the pediatric population.

Main Methods:

  • This article is a review and synthesis of current knowledge on pediatric sepsis.
  • It focuses on the clinical presentation, diagnosis, and management strategies.
  • Emphasis is placed on the unique aspects of sepsis in neonates, infants, and children.

Main Results:

  • Sepsis presents unique challenges in pediatric patients compared to adults.
  • Early recognition and prompt treatment are critical for improving outcomes.
  • Understanding the specific pathophysiology in children is essential for effective care.

Conclusions:

  • Sepsis remains a critical concern in pediatric intensive care.
  • Collaborative, multidisciplinary approaches are necessary for optimal management.
  • Further research into pediatric-specific sepsis treatments is warranted.

More Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...